Royalty Pharma Plc (RPRX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: GB00BMVP7Y09

Royalty Pharma plc, listed on NASDAQ as RPRX, is a key player in the biopharmaceutical industry in the U.S. Their primary focus is acquiring biopharmaceutical royalties and supporting innovations within the sector. Apart from buying royalties, they actively identify, assess, and secure royalties for various biopharmaceutical treatments.

The company stands out for their collaborative approach, working closely with a diverse range of innovators from academic institutions, research hospitals, not-for-profits, as well as small to mid-cap biotechnology and pharmaceutical firms. This collaborative effort helps in expanding their portfolio and staying at the forefront of emerging trends in the industry.

With a robust portfolio, Royalty Pharma plc currently holds royalties for around 35 commercial products and has investments in 14 development-stage product candidates. Their focus areas include rare diseases, cancer, neuroscience, immunology, respiratory diseases, infectious diseases, hematology, and diabetes treatments, showcasing their commitment to diverse therapeutic fields.

The company has a rich history, being established in 1996 and headquartered in New York, New York. For more information, you can visit their website at

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Royalty Pharma Plc (RPRX) - Stock Price & Dividends

RPRX Stock Overview

Market Cap in USD 17,875m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1993-03-25

RPRX Stock Ratings

Fundamental 2.63
Dividend 6.78
Growth 5y -1.30
Rel. Performance vs Sector -2.81
Analysts 4.50
Fair Price Total Ret. 30.16
Fair Price DCF 183.33

RPRX Dividends

Yield 12m 2.59%
Yield on Cost 5y 3.12%
Dividends CAGR 5y 7.46%
Payout Consistency 100.0%

RPRX Growth Ratios

Growth 12m -10.88%
Growth Correlation 12m -54%
Growth Correlation 3m 57%
CAGR 5y 5.13%
CAGR / Mean Drawdown 0.21
Sharpe Ratio 12m -0.65
Alpha vs SP500 12m -37.84
Beta vs SP500 5y weekly 0.88
CAPM 7.67%
Average Daily Range 2m 2.41%
Regime Oscillator 95.82
Volatility GJR Garch 1y 25.22%
Price / SMA 50 9.36%
Price / SMA 200 8.12%
Current Volume 2423.3k
Average Volume 20d 3438.6k

External Links for RPRX Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of RPRX stocks?
As of February 28, 2024, the stock is trading at USD 31.30 with a total of 2,423,349 shares traded.
Over the past week, the price has changed by +3.30%, over one month by +8.30%, over three months by +16.16% and over the past year by -10.88%.
Why is RPRX stock down?
Check with which Index or Commodity RPRX has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return RPRX Return S&P 500
1 Month 8.30% 4.00%
3 Months 16.16% 11.99%
12 Months -10.88% 29.39%
What is the forecast for RPRX stock price target?
According to ValueRays Forecast Model, RPRX Royalty Pharma Plc will be worth about 33 in February 2025. The stock is currently trading at 31.30. This means that the stock has a potential upside of +5.43%.
Issuer Forecast Upside
Wallstreet Target Price 46.6 48.8%
Analysts Target Price 48.7 55.5%
ValueRay Target Price 33 5.4%